|
| View:
Latest News | Top Stories |
|
| 1.
|
Merck declares dividend and $3B stock buyback
-
AP
-
Tue 3:45 pm ET
Drugmaker Merck & Co. declared a quarterly dividend of 38 cents on Tuesday, and said it plans to buy back as much as $3 billion in stock.
|
|
| 2.
|
GlaxoSmithKline pulls swine flu vaccines in Canada
-
AP
-
Tue 10:16 am ET
Canadian doctors have been advised not to use a batch of 170,000 swine flu vaccines after six reports of serious allergic reactions among recipients, but there are no similar reports from other countries, pharmaceuticals company GlaxoSmithKline PLC said Tuesday.
|
|
| 3.
|
Global Pharmaceuticals Awards Grant to Myasthenia Gravis Alliance
-
Business Wire
-
Tue 9:30 am ET
HAYWARD, Calif.----Global Pharmaceuticals, the generic products division of Impax Laboratories, Inc. , today announced their cooperation in awarding a modest grant to Myasthenia Gravis Alliance, also known as Myasthenia Gravis Foundation of Greater New York, Inc., a 501 non profit membership corporation, incorporated in the State of New York.
|
|
| 4.
|
Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
-
PR Newswire
-
Tue 8:30 am ET
Keryx Biopharmaceuticals, Inc. today announced that Ron Bentsur, the Company's Chief Executive Officer, is scheduled to present at the Piper Jaffray 21st Annual Health Care Conference being held in New York City.
|
|
| 5.
|
Merck says key Fosamax lawsuit dismissed
-
AP
-
Tue 7:40 am ET
Merck & Co. on Tuesday said a U.S. district court dismissed claims against the company in a second key case alleging the osteoporosis drug Fosamax causes painful jaw bone destruction.
|
|
| 6.
|
GlaxoSmithKline pulls application for new drug use
-
AP
-
Mon 1:52 pm ET
British drugmaker GlaxoSmithKline PLC said Monday it is temporarily withdrawing its application for U.S. approval of a drug to prevent prostate cancer.
|
|
| 7.
|
Positive Opinion for Merck's Elonva
-
Zacks.com
-
Mon 10:30 am ET
Merck has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Elonva . Merck would now be able to market Elonva with unified labeling valid in all European Union Member States.
|
|
| 8.
|
Good News for Bristol-Myers
-
Zacks.com
-
Mon 9:07 am ET
Bristol-Myers receives approval to market Abilify for treatment of irritability in pediatric patients having autistic disorder.
|
|
| 9.
|
Big Pharma Mergers: Good News Or Bad?
-
Investor's Business Daily
-
Fri Nov 20
Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year.
|
|
| 10.
|
AstraZeneca Seeks FDA Approval
-
Zacks.com
-
Fri Nov 20
AstraZeneca plc has announced the submission of a New Drug Application to the U.S. Food and Drug Administration for its blood clot preventer Brilinta.
|
|
